Does inhibiting glutamine metabolism impact tumor cells or the microenvironment?
A new editorial paper was published in Oncotarget, titled "Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?"
Aug 16, 2023
0
72
MeSH tree: D08.811.277.087
A new editorial paper was published in Oncotarget, titled "Inhibition of glutamine metabolism: acting on tumoral cells or on tumor microenvironment?"
Aug 16, 2023
0
72
As the United States faces a growing obesity epidemic, scientists are taking a closer look at how body weight can affect health outcomes. New research published in Blood Advances highlights the potential association of elevated ...
Jul 13, 2023
0
41
Doctors have long puzzled over a mystery at the heart of fibrolamellar carcinoma, a rare and deadly liver cancer that mainly affects children and young adults. Like more common liver cancers, and liver failure itself, fibrolamellar ...
Jun 29, 2023
0
61
The biology underpinning a rare genetic mutation that allows its carrier to live virtually pain-free, heal more rapidly and experience reduced anxiety and fear, has been uncovered by new research from UCL.
May 23, 2023
1
474
A new research paper was published in Aging, titled "Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic."
Apr 25, 2023
0
75
Consuming a diet rich in vitamin A or its analogs may help prevent children and young adults with acute lymphoblastic leukemia (ALL) reduce their risk of developing painful pancreas inflammation during chemotherapy treatment.
Mar 15, 2023
0
92
In stem cell transplants, which are used for the treatment of leukemia, the patient's hematopoietic system is eliminated and replaced by hematopoietic cells from donors. Even though the amount of complications occurring in ...
Feb 9, 2023
0
53
Aging has been long believed to occur through accumulated mutations to DNA, which gradually interfere with the normal functioning of cells, tissues, and organs. In January, Harvard researchers reported that they'd turned ...
Jan 31, 2023
0
57
Scientists at St. Jude Children's Research Hospital are reporting the most comprehensive study to date describing the variations in drug response across different genetic subtypes of acute lymphoblastic leukemia (ALL). The ...
Jan 5, 2023
0
54
Cambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The approach is a step towards the development of new treatments to prevent relapse in patients.
Dec 20, 2022
0
54